Procept Biorobotics Insider Sold Shares Worth $1,811,653, According to a Recent SEC Filing
Express News | Procept Biorobotics Corp : Leerink Partners Raises Target Price to $86 From $78
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), PROCEPT BioRobotics (PRCT) and Travere Therapeutics (TVTX)
A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $75 to $99
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
PRCT Stock Rises on FDA's Nod to Initiate Study on Prostate Cancer